Development of autoantibodies after pediatric liver transplantation.
about
Progressive Fibrosis Is Driven by Genetic Predisposition, Allo-immunity, and Inflammation in Pediatric Liver Transplant Recipients.De novo autoimmune hepatitis after liver transplantation: A focus on glutathione S-transferase theta 1.Lack of Clinical Relevance of ANA and ASMA Positivity in Patients with Liver Transplantation without a History of Autoimmune DiseasesAutoimmunity after liver transplantation: a frequent event but a rare clinical problem.
P2860
Development of autoantibodies after pediatric liver transplantation.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Development of autoantibodies after pediatric liver transplantation.
@en
Development of autoantibodies after pediatric liver transplantation.
@nl
type
label
Development of autoantibodies after pediatric liver transplantation.
@en
Development of autoantibodies after pediatric liver transplantation.
@nl
prefLabel
Development of autoantibodies after pediatric liver transplantation.
@en
Development of autoantibodies after pediatric liver transplantation.
@nl
P2860
P50
P356
P1476
Development of autoantibodies after pediatric liver transplantation
@en
P2093
Ching-Yi Chen
Huey-Ling Chen
P2860
P304
P356
10.1111/PETR.12032
P577
2012-12-06T00:00:00Z